Poroid hidradenoma of the eyelid: a case report
-
By
-
Christian Nieves-Rios
-
José J. López-Fontanet
-
Juan Serrano-Olmo
-
Joseph Campbell
-
May 7, 2026
-
Clinical Scorecard: Poroid Hidradenoma in the Eyelid: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Poroid Hidradenoma (PH) |
| Key Mechanisms | Non-cancerous neoplasm from eccrine sweat glands, characterized by solid and cystic formations. |
| Target Population | Individuals in their sixth to seventh decades of life, but can occur in a wide age range. |
| Care Setting | Ophthalmology and dermatology clinics. |
Key Highlights
- PH is a rare, benign neoplasm primarily affecting eccrine gland-rich areas.
- Histopathological examination is crucial for accurate diagnosis.
- Surgical excision is the standard treatment to prevent potential malignant transformation.
- Recurrence is infrequent, with a follow-up showing no signs of recurrence in the presented case.
Guideline-Based Recommendations
Diagnosis
- Histological examination is essential for diagnosis.
- Immunohistochemical staining may assist in ambiguous cases.
Management
- Surgical excision with clear margins (2–3 mm) is recommended.
Monitoring & Follow-up
- Initial close monitoring for recurrent or atypically situated lesions, with biannual or annual assessments as needed.
Risks
- Malignant transformation is rare, occurring in fewer than 1% of cases.
Patient & Prescribing Data
Older adults, particularly those in their sixth to seventh decades.
Surgical resection is effective, with low recurrence rates observed.
Clinical Best Practices
- Recognize ocular signs of PH for accurate diagnosis.
- Ensure thorough histopathological evaluation for definitive diagnosis.
Related Resources & Content
